Mingxing Xu

No. 600 Tianhe Road
Guangzhou, 510630, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Time-trends in liver cancer incidence and mortality rates in the U.S. from 1975 to 2017: a study based on the Surveillance, Epidemiology, and End Results database.

Time-trends in liver cancer incidence and mortality rates in the U.S. from 1975 to 2017: a study based on the Surveillance, Epidemiology, and End Results database.

Journal: Journal of gastrointestinal oncology

Published: December 14, 2022

Bone marrow mesenchymal stem cells inhibit hepatic fibrosis via the AABR07028795.2/rno-miR-667-5p axis.

Bone marrow mesenchymal stem cells inhibit hepatic fibrosis via the AABR07028795.2/rno-miR-667-5p axis.

Journal: Stem cell research & therapy

Published: July 29, 2021

Occurrence and distribution of per- and polyfluoroalkyl substances (PFASs) in human livers with liver cancer.

Occurrence and distribution of per- and polyfluoroalkyl substances (PFASs) in human livers with liver cancer.

Journal: Environmental research

Published: June 09, 2021

Expression and prognostic roles of PRDXs gene family in hepatocellular carcinoma.

Expression and prognostic roles of PRDXs gene family in hepatocellular carcinoma.

Journal: Journal of translational medicine

Published: October 28, 2020

Identification of miRNAs as diagnostic and prognostic markers in hepatocellular carcinoma.

Identification of miRNAs as diagnostic and prognostic markers in hepatocellular carcinoma.

Journal: Aging

Published: February 28, 2020

Inhibiting Th1/2 cells influences hepatic capillarization by adjusting sinusoidal endothelial fenestrae through Rho-ROCK-myosin pathway.

Inhibiting Th1/2 cells influences hepatic capillarization by adjusting sinusoidal endothelial fenestrae through Rho-ROCK-myosin pathway.

Journal: Aging

Published: January 13, 2020

Value of KPNA4 as a diagnostic and prognostic biomarker for hepatocellular carcinoma.

Value of KPNA4 as a diagnostic and prognostic biomarker for hepatocellular carcinoma.

Journal: Aging

Published: January 09, 2020

Identification of CELSR2 as a novel prognostic biomarker for hepatocellular carcinoma.

Identification of CELSR2 as a novel prognostic biomarker for hepatocellular carcinoma.

Journal: BMC cancer

Published: September 21, 2019

Circ_0001955 facilitates hepatocellular carcinoma (HCC) tumorigenesis by sponging miR-516a-5p to release TRAF6 and MAPK11.

Circ_0001955 facilitates hepatocellular carcinoma (HCC) tumorigenesis by sponging miR-516a-5p to release TRAF6 and MAPK11.

Journal: Cell death & disease

Published: August 15, 2019

Long noncoding RNA MALAT1 potentiates growth and inhibits senescence by antagonizing ABI3BP in gallbladder cancer cells.

Long noncoding RNA MALAT1 potentiates growth and inhibits senescence by antagonizing ABI3BP in gallbladder cancer cells.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 04, 2019

Antiviral therapy predicts the outcomes following resection of hepatocellular carcinoma in patients negative for HBV DNA: a propensity score matching analysis.

Antiviral therapy predicts the outcomes following resection of hepatocellular carcinoma in patients negative for HBV DNA: a propensity score matching analysis.

Journal: World journal of surgical oncology

Published: October 20, 2018

TRIM29 prevents hepatocellular carcinoma progression by inhibiting Wnt/β-catenin signaling pathway.

TRIM29 prevents hepatocellular carcinoma progression by inhibiting Wnt/β-catenin signaling pathway.

Journal: Acta biochimica et biophysica Sinica

Published: June 07, 2018

Showing 1-12 of 14

Last Updated: 09/26/2026